Fecal occult blood testing done in setting of an office-based digital rectal exam is not useful

Evidence-Based Gastroenterology

Volumn 6, Issue 2, 2005, Pages 44-45

  Collins, Judith F ^a   Lieberman, D A ^c   Durbin, T E ^c   Weis, D G ^c   Smalley, Walter ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; FECES ANALYSIS; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MEDICAL DECISION MAKING; OCCULT BLOOD; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 19044375832     PISSN: 15278557     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ebg.0000163173.48492.d8     Document Type: Short Survey

References (3)

1. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162-168.
2. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129-131.
3. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005;142:86-94.